Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) saw a large increase in short interest in June. As of June 15th, there was short interest totalling 294,700 shares, an increase of 8.1% from the May 31st total of 272,600 shares. Based on an average daily volume of 123,600 shares, the short-interest ratio is presently 2.4 days.

Wall Street Analyst Weigh In

A number of brokerages have commented on ADUS. Barclays lowered Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a report on Tuesday, April 23rd. Bank of America upped their price objective on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. StockNews.com raised Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Saturday. Oppenheimer increased their target price on Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. Finally, TD Cowen increased their target price on Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a report on Tuesday, June 18th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus target price of $116.25.

Check Out Our Latest Analysis on Addus HomeCare

Addus HomeCare Price Performance

Addus HomeCare stock opened at $116.16 on Tuesday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The company has a market capitalization of $1.90 billion, a PE ratio of 28.82, a P/E/G ratio of 1.77 and a beta of 1.01. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $120.53. The stock has a 50-day moving average price of $110.16 and a two-hundred day moving average price of $100.11.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $0.97 by $0.24. The firm had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The business’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period last year, the company earned $0.84 earnings per share. Analysts expect that Addus HomeCare will post 4.36 EPS for the current year.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 217 shares of the company’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,186,500.21. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Large investors have recently bought and sold shares of the company. Exchange Traded Concepts LLC boosted its holdings in Addus HomeCare by 0.8% in the fourth quarter. Exchange Traded Concepts LLC now owns 14,310 shares of the company’s stock valued at $1,329,000 after acquiring an additional 113 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Addus HomeCare by 40.8% during the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock worth $57,000 after buying an additional 161 shares during the period. ProShare Advisors LLC increased its position in shares of Addus HomeCare by 7.3% during the first quarter. ProShare Advisors LLC now owns 3,163 shares of the company’s stock worth $327,000 after buying an additional 214 shares during the period. Pitcairn Co. increased its position in shares of Addus HomeCare by 6.2% during the first quarter. Pitcairn Co. now owns 3,840 shares of the company’s stock worth $397,000 after buying an additional 225 shares during the period. Finally, Hancock Whitney Corp increased its position in shares of Addus HomeCare by 5.4% during the first quarter. Hancock Whitney Corp now owns 5,102 shares of the company’s stock worth $527,000 after buying an additional 263 shares during the period. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.